Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00973817 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis
A Phase 2 study of Acute On Chronic Hepatitis, sponsored by Vital Therapies.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
- 20
- Study locations
NCT00973817 is a Phase 2 study of Acute On Chronic Hepatitis that has completed, run by Vital Therapies. The registered enrollment target is 62 participants. The trial reports 20 study locations across 10 states.
The verdict
NCT00973817, a Phase 2 study of Acute On Chronic Hepatitis, has completed, sponsored by Vital Therapies.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to investigate the safety and efficacy of the use of ELAD in patients with diagnosed Acute On Chronic Hepatitis, including Acute Alcoholic Hepatitis.
Conditions Studied
Interventions
- OTHER Standard of care
- BIOLOGICAL ELAD plus standard of care treatment
Study Locations (20)
New York
- New York University Medical Center - New York
- Columbia University Medical Center - New York
- Univ. of Rochester, Strong Memorial Hospital - Rochester
- Westchester Medical Center - Valhalla
Pennsylvania
- Drexel University College of Medicine - Philadelphia
- Temple University - Philadelphia
- Albert Einstein Medical Center - Philadelphia
Other
- Royal Derby Hospital - Derby
- Edinburgh Royal Infirmary - Edinburgh
- St. James University Hospital - Leeds
California
- Cedars Sinai Medical Center - Los Angeles
- California Pacific Medical Center - San Francisco
Texas
- The Liver Institute at Methodist Dallas Medical Center - Dallas
- Baylor University Medical Center - Dallas
England
- University Hospitals Birmingham - Birmingham
- Kings College Hospital NHS Foundation Trust - London
Illinois
- University of Chicago Medical Center - Chicago
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00973817
The ClinicalTrials.gov registry entry for NCT00973817 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vital Therapies, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute On Chronic Hepatitis appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT00973817 reports 20 study locations spanning 10 distinct geographic areas - top geographies include New York, Pennsylvania, Other.
Frequently Asked Questions
What is clinical trial NCT00973817 about?
NCT00973817 is a clinical study titled "Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis". The purpose of this study is to investigate the safety and efficacy of the use of ELAD in patients with diagnosed Acute On Chronic Hepatitis, including Acute Alcoholic Hepatitis.
What is the current status of trial NCT00973817?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2009-09. Estimated completion is 2011-05.
What conditions does trial NCT00973817 study?
This clinical trial studies the following conditions: Acute On Chronic Hepatitis.
What interventions are being tested in trial NCT00973817?
The interventions under investigation include: Standard of care (OTHER), ELAD plus standard of care treatment (BIOLOGICAL).
Who is sponsoring clinical trial NCT00973817?
This trial is sponsored by Vital Therapies, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00973817 being conducted?
This trial has 20 study locations across California, Illinois, Indiana, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.